Therapeutic Delivery – Products

Liposomes are nowadays frequently used as drug delivery systems, and as such requires that they are well characterized for manufacturing and batch release.

Isogenica Ltd announced that it has signed a new licensing agreement with Aro Biotherapeutics Company (Aro) of Philadelphia. USA.

New surfactant replacement offers a promising alternative to polysorbates for stabilizing proteins.

Thanks to this Premium partnership, researchers can combine the femtoliters scale fluid control and cell treatment precision of FluidFM with the force control, resolution and speed available with Bruker’s exclusive PeakForce Tapping® technology.

TRIGR Therapeutics, a US-based Biopharmaceutical company, and ABL Bio Corporation, a South Korean biotechnology company, jointly announced that it had entered into a binding agreement for TRIGR to license the global commercial rights to ABL Bio’s pipeline of novel therapeutic antibodies to treat cancer.

PNI and Evonik will also establish a demonstration area to showcase the NanoAssemblr suite of products in Darmstadt, Germany. This facility will be used for performing hands-on demonstrations, seminars, workshops and training programs for potential customers.

Bio-cannabis product pipeline ready to be commercialized In Canada.

Syrris, a world leader in chemistry product innovation, continues to support pioneering research into nanoparticle drug encapsulation, thanks to its award-winning Asia range of advanced flow chemistry modules.

Dolomite Microfluidics is simplifying research into drug encapsulation by offering a complete automated system for polymer micro- and nanoparticle generation.

AMSBIO announces that its exosome product range now includes everything you need for studying and using exosomes, from isolation and characterization, to cargo profiling and engineering, and more.